Equities
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)4,950.00
  • Today's Change55.00 / 1.12%
  • Shares traded4.96m
  • 1 Year change+22.07%
  • Beta1.2474
Data delayed at least 20 minutes, as of Sep 19 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments876,866607,606778,745
Total Receivables, Net454,206349,245266,937
Total Inventory438,111301,608217,910
Prepaid expenses------
Other current assets, total404,841236,59281,679
Total current assets2,174,0241,495,0511,345,271
Property, plant & equipment, net421,692348,912304,070
Goodwill, net108,49898,33083,555
Intangibles, net168,300159,609163,884
Long term investments147,965131,146132,723
Note receivable - long term--41181
Other long term assets191,30295,70453,545
Total assets3,461,1352,508,8892,221,402
LIABILITIES
Accounts payable88,74080,38768,538
Accrued expenses------
Notes payable/short-term debt000
Current portion long-term debt/capital leases12,84052,32531,088
Other current liabilities, total621,819397,551295,642
Total current liabilities723,399530,263395,268
Total long term debt143,162140,531182,527
Total debt156,002192,856213,615
Deferred income tax12,85812,64712,444
Minority interest429----
Other liabilities, total893,113379,594280,291
Total liabilities1,772,9611,063,035870,530
SHAREHOLDERS EQUITY
Common stock50,00050,00050,000
Additional paid-in capital1,962----
Retained earnings (accumulated deficit)1,388,8421,231,7881,170,208
Treasury stock - common(36629)(36808)(37482)
Unrealized gain (loss)------
Other equity, total283,999200,874168,146
Total equity1,688,1741,445,8541,350,872
Total liabilities & shareholders' equity3,461,1352,508,8892,221,402
Total common shares outstanding1,9181,9171,917
Treasury shares - common primary issue303030
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.